The term "COAC2" may represent a typographical error or unstandardized nomenclature. The following candidates represent the closest matches in existing research:
While "COAC2" remains unidentified, the search results highlight methodological approaches for characterizing antibodies:
Antibody Titers vs. Protection: Anti-spike IgG levels >5,000 AU correlate with >90% ACE2 binding inhibition, reducing breakthrough infections .
Broad-Spectrum Design: Computational engineering restores antibody potency against viral variants (e.g., 2130-1-0114-112 ).
Verify Terminology: Confirm whether "COAC2" refers to a novel target, a proprietary compound, or a typographical error (e.g., COG2, CA2).
Explore Patent Databases: Unpublished or industry-specific antibodies may not appear in academic journals.
Expand Search Parameters: Include combinations like "COAC2 + [disease context]" or "COAC2 + [structural motif]."
COAC2 (Graves disease carrier protein) is a protein-coding gene found in plant species including Arabidopsis thaliana. This protein has structural similarities to carrier proteins and may be involved in molecular transport mechanisms within plant cells. The protein is identified with the Uniprot number F4JU70 and has homologs in other plant species such as Solanum lycopersicum (tomato) where it is associated with gene ID LOC101266696 . Understanding COAC2's function is relevant for researchers studying plant molecular transport systems, cellular metabolism, and potentially stress responses. The antibody against this protein enables visualization and quantification of COAC2 in various experimental contexts, making it a valuable tool for plant biochemistry and molecular biology research.
The COAC2 antibody (CSB-PA561773XA01DOA) has been specifically validated for ELISA (Enzyme-Linked Immunosorbent Assay) applications . This validation ensures researchers can reliably use this antibody for quantitative detection of COAC2 protein in solution. While ELISA is the primary verified application, researchers commonly adapt antibodies for other immunological techniques following appropriate optimization protocols. It's important to note that this antibody is designated "For Research Use Only" and not for diagnostic or therapeutic procedures . Before attempting applications beyond ELISA, researchers should perform their own validation tests to confirm specificity and sensitivity in their specific experimental system.
For maximum stability and retention of immunoreactivity, the COAC2 antibody should be stored at either -20°C or -80°C upon receipt . Repeated freeze-thaw cycles significantly degrade antibody quality and should be avoided. For optimal preservation:
| Storage Parameter | Recommendation | Rationale |
|---|---|---|
| Temperature | -20°C to -80°C | Prevents protein denaturation and maintains epitope recognition |
| Aliquoting | Small single-use volumes | Minimizes freeze-thaw cycles |
| Thawing | Slow thaw at 4°C | Reduces protein aggregation |
| Working solution | Store at 4°C for up to 2 weeks | Balances convenience with stability |
Researchers should monitor antibody performance over time, as even properly stored antibodies may experience gradual loss of activity. Documentation of lot numbers and performance across experiments is recommended for longitudinal studies.
Validating antibody specificity is crucial for generating reliable research data with COAC2 antibody. Since this antibody is raised against recombinant Arabidopsis thaliana COAC2 protein , researchers should implement multiple validation approaches:
Western blot analysis comparing wild-type Arabidopsis with COAC2 knockout/knockdown lines to confirm absence of signal in mutant lines
Peptide competition assays where pre-incubation of the antibody with excess purified COAC2 protein should abolish signal
Immunoprecipitation followed by mass spectrometry to confirm the identity of pulled-down proteins
Cross-reactivity testing with closely related proteins to ensure signal specificity
When presenting results, researchers should include all validation data alongside experimental findings to establish credibility. For negative results, thorough validation becomes even more critical to distinguish between true biological phenomena and technical limitations of the antibody.
While the COAC2 antibody is primarily validated for ELISA , researchers can adapt it for immunolocalization studies with careful optimization:
Fixation optimization: Test multiple fixatives (4% paraformaldehyde, glutaraldehyde combinations) as plant tissues often require specific fixation protocols to preserve antigenicity while maintaining cellular structure.
Antigen retrieval: For formalin-fixed tissues, try citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) heat-mediated retrieval to expose epitopes.
Blocking optimization: Test different blocking solutions (3-5% BSA, normal serum from the same species as secondary antibody) to reduce background.
Antibody dilution series: Create a dilution series (typically 1:100 to 1:1000) to determine optimal signal-to-noise ratio.
Signal amplification: For low-abundance proteins, consider tyramide signal amplification or quantum dot labeling.
The optimal protocol should produce specific labeling in wild-type samples with minimal background and absence of signal in negative controls (primary antibody omission, COAC2 knockout tissues).
Investigating COAC2 protein interactions during stress responses requires specialized immunological approaches:
Co-immunoprecipitation (Co-IP): Use COAC2 antibody to pull down protein complexes from plant tissues under various stress conditions. This requires optimization of:
Lysis buffers (test multiple detergent concentrations)
Antibody concentration (typically 2-5 μg per mg of total protein)
Incubation conditions (4°C overnight with gentle rotation)
Proximity ligation assay (PLA): This technique can visualize protein interactions in situ with spatial resolution:
Requires a second antibody against the suspected interaction partner
Provides single-molecule resolution of interaction events
Allows quantification of interaction frequency under different conditions
Chromatin immunoprecipitation (ChIP) if COAC2 may have DNA-binding properties:
Optimize crosslinking conditions for plant tissues
Include appropriate controls (IgG, input samples)
When experiencing poor signal in Western blots with COAC2 antibody, consider these methodological adjustments:
| Issue | Potential Solution | Implementation Details |
|---|---|---|
| Low protein expression | Increase protein loading | Use 30-50 μg total protein; concentrate samples if necessary |
| Inefficient transfer | Optimize transfer conditions | For high MW proteins, use longer transfer times or lower SDS concentration |
| Epitope masking | Modify sample preparation | Test different lysis buffers; avoid strong reducing agents if disulfide bonds are crucial |
| Antibody concentration | Increase antibody concentration | Try 1:500 dilution instead of recommended 1:1000 |
| Detection sensitivity | Switch detection methods | Try HRP-conjugated chemiluminescence or fluorescent secondary antibodies |
| Protein degradation | Add protease inhibitors | Use fresh, complete protease inhibitor cocktail in all buffers |
It's important to note that COAC2 antibody has been specifically validated for ELISA applications , so Western blot protocols will require additional optimization. If signals remain problematic after these adjustments, consider enriching for membrane fractions if COAC2 is predicted to be membrane-associated based on its possible carrier protein function.
For quantitative analysis of COAC2 expression across tissues, researchers should employ these methodological approaches:
Quantitative ELISA:
Develop a standard curve using recombinant COAC2 protein
Process all tissue samples identically (extraction buffer, protein quantification)
Run technical triplicates and biological replicates (minimum n=3)
Include an internal control protein for normalization
Western blot quantification:
Use housekeeping proteins (actin, tubulin) for normalization
Ensure signal is within linear detection range
Apply densitometry software (ImageJ) with consistent analysis parameters
Include a standard curve with recombinant protein if absolute quantification is needed
High-content imaging:
When using immunofluorescence, standardize image acquisition parameters
Apply automated analysis algorithms to quantify signal intensity
Report results as mean fluorescence intensity normalized to cell count or tissue area
Reliable quantification requires statistical analysis of multiple biological replicates and consideration of tissue-specific extraction efficiency variations.
If research suggests COAC2 may interact with DNA or chromatin-associated proteins, adapting the antibody for ChIP requires these specialized considerations:
Crosslinking optimization:
Test formaldehyde concentrations (1-3%) and incubation times (10-20 minutes)
For plant tissues, vacuum infiltration improves crosslinking efficiency
Quench with glycine (final concentration 125 mM)
Chromatin extraction and shearing:
Optimize sonication parameters for fragment sizes of 200-500 bp
Verify fragmentation efficiency by agarose gel electrophoresis
Pre-clear chromatin with protein A/G beads to reduce background
Immunoprecipitation conditions:
COAC2 antibody amount: typically 2-5 μg per ChIP reaction
Include IgG control and input samples (5-10% of starting material)
Incubate overnight at 4°C with rotation
Validation of ChIP efficiency:
Perform qPCR on known targets and negative control regions
Calculate percent input and fold enrichment over IgG control
Since the COAC2 antibody is raised in rabbit , protein A-based resins often provide optimal capture efficiency. The antibody's ability to recognize native, crosslinked COAC2 protein should be verified before proceeding with full ChIP-seq experiments.
To investigate COAC2 protein turnover and degradation mechanisms, researchers can employ these specialized approaches:
Cycloheximide chase assays:
Treat plants/cells with cycloheximide to inhibit protein synthesis
Harvest samples at multiple time points (0, 1, 3, 6, 12, 24 hours)
Perform Western blot using COAC2 antibody
Quantify protein levels relative to time zero and calculate half-life
Proteasome inhibitor studies:
Treat samples with MG132 or other proteasome inhibitors
Compare COAC2 levels with and without inhibitor
Accumulation in inhibitor-treated samples suggests proteasomal degradation
Ubiquitination detection:
Immunoprecipitate COAC2 using the antibody
Probe with anti-ubiquitin antibodies
Alternatively, co-express tagged ubiquitin and perform sequential immunoprecipitation
Pulse-chase experiments:
Label newly synthesized proteins with 35S-methionine
Chase with non-radioactive medium
Immunoprecipitate COAC2 at various timepoints
Visualize by autoradiography and quantify degradation rate
When reporting results, include half-life calculations and statistical analysis of degradation rates under different conditions to robustly characterize COAC2 stability.
The COAC2 antibody is specifically raised against Arabidopsis thaliana COAC2 protein , but may have application in comparative studies with careful methodological considerations:
Cross-reactivity assessment:
Perform sequence alignment analysis of COAC2 across species
Test antibody recognition in Western blots using protein extracts from multiple species
Quantify relative signal strength as indication of epitope conservation
Epitope mapping:
If the epitope sequence is known, analyze conservation across species
For polyclonal antibodies, consider affinity purification against conserved epitopes
Validation controls for cross-species studies:
Include positive controls (Arabidopsis samples)
Use genetic knockouts or knockdowns in test species when available
Employ peptide competition assays in each new species
Potential comparative studies could explore COAC2 homologs in Solanum lycopersicum and other plants, examining evolutionary conservation of expression patterns, subcellular localization, and protein-protein interactions. Such studies would contribute to understanding evolutionary conservation of COAC2 function across plant lineages.
When investigating COAC2's role in stress responses, methodological considerations include:
Stress treatment standardization:
Define precise stress conditions (duration, intensity)
Include appropriate stress markers as positive controls
Document plant developmental stage and growth conditions
Temporal analysis:
Perform time-course studies to capture dynamic changes
Include early (0-3h), intermediate (6-12h), and late (24-72h) timepoints
Correlate protein changes with transcriptional responses
Subcellular fractionation:
Separate cellular compartments to track potential translocation
Verify fraction purity with compartment-specific markers
Quantify relative distribution across fractions
Protein modification detection:
Assess post-translational modifications using phospho-specific stains
Use 2D gel electrophoresis to detect charge variants
Consider mass spectrometry to identify specific modifications
Functional correlation:
Correlate COAC2 levels/modifications with physiological parameters
Compare wild-type and COAC2-modified plants under identical stress conditions
These approaches enable comprehensive characterization of COAC2's potential role in plant stress responses, particularly if it functions as a carrier protein involved in stress adaptation mechanisms.